CME’s $192bn balance sheet was 81% matched clearing collateral

CME Group reported $192.093 billion of total assets at September 30, 2026. The number makes the derivatives-market operator appear balance-sheet-sized like a very large bank. Its footnotes show a different economic structure: $155.180 billion—80.8% of the asset total—was performance-bond and guaranty-fund collateral, matched by an equal liability. Removing that matched clearing item from both sides leaves $36.913 billion of reported assets, not because the collateral is unreal, but because it is not deployable corporate capital.[1]

The distinction changes how leverage, liquidity and earnings should be read. CME receives cash and securities from clearing firms to secure obligations, holds or reinvests that collateral under clearing rules, and owes the corresponding amount back through the clearing system. The gross asset enlarges the consolidated balance sheet; the matching liability preserves the obligation. Treating the $155.2 billion as unrestricted cash available for acquisitions, dividends or debt repayment would confuse custody-like clearing resources with the company’s own financial capacity.[1][3]

The adjusted $36.913 billion should not be mistaken for “net assets.” CME also has ordinary liabilities, debt, goodwill and intangible assets. Equity must still be read from the full balance sheet. The subtraction is a perimeter test: it isolates how much of the asset total comes from a line that has an equal and opposite liability and a specialised clearing purpose.[1]

Why the collateral is on both sides

A central counterparty stands between buyers and sellers after trades are cleared. Clearing firms post initial and maintenance performance bonds, commonly described as margin, and contribute to guaranty funds. CME marks positions to market and transfers settlement variation from firms whose positions lost value to firms whose positions gained value. During the first nine months of 2026, it moved an average of approximately $8.2 billion a day through those settlement systems.[1][3]

The performance-bond asset records collateral held or reinvested by CME. The equal liability reflects that CME does not own the collateral free of the clearing obligation. The company classifies cash performance bonds and guaranty-fund contributions as restricted cash and restricted cash equivalents in the cash-flow statement. That label is the accounting boundary missed when the headline asset total is treated as a conventional corporate treasury balance.[1]

At September 30, CME held $139.1 billion in its cash account at the Federal Reserve Bank of Chicago, included within the $155.2 billion collateral asset. That means roughly 89.6% of the matched collateral line was in the Fed account. Systemically important financial-market-utility status gives CME access to that account, but access does not convert the balances into distributable shareholder funds. Their function remains clearing and settlement.[1]

The “other” amount is a subtraction, not a separately disclosed portfolio value, and the composition can move with clearing-firm deposits. CME says its reinvestment options can include commercial and central-bank deposits, government securities, reverse repurchase agreements and money-market funds. The table therefore describes location and scale, not a claim that all non-Fed collateral sat in one asset class.[1]

The collateral generates income—but most of the gross return is passed back

The balance is not economically inert. CME reinvests cash collateral and distributes a portion of the interest earned to clearing firms. For the first nine months of 2026, it reported $4.1515 billion of earnings on cash performance bonds and guaranty-fund contributions and $3.7839 billion of related interest-distribution expense. A simple subtraction leaves $367.6 million. In the third quarter alone, $1.3917 billion of earnings less $1.2690 billion of distributions leaves $122.7 million.[1]

Those residuals are analytical bridges, not a substitute for CME’s reported investment income. The filing also refers to unrealised gains or losses and other items. Nor do they imply that the entire collateral base earned the same rate for the full period: balances move daily, collateral arrives in different forms, and the return and distribution rates vary. The defensible finding is that the gross interest headline overstates CME’s retained economics because most of it is contractually or operationally distributed back.[1]

The year-on-year direction illustrates the interaction. Nine-month gross earnings rose despite a lower average return because average reinvestment balances were higher; the third-quarter gross figure fell because the lower rate outweighed higher balances. A broker or exchange comparison that divides gross collateral earnings by period-end collateral would mix a flow with a point-in-time stock and ignore distributions. The proper analysis requires average eligible balances and the net retained spread, neither of which is fully supplied in one headline figure.[1]

The matched liability is not the same as CME’s settlement guarantee

CME also provides a settlement guarantee when it becomes the buyer to every seller and the seller to every buyer. Management estimates the fair value of that guarantee liability as nominal and records no liability for it. That conclusion sits alongside the $155.2 billion matched collateral liability but describes a different exposure. One is the obligation associated with collateral received; the other is a contingent clearing guarantee assessed through the default-management framework.[1]

The company says it has not historically recognised significant losses on performance-bond collateral posted by clearing firms and has not recorded a credit-loss allowance on those assets or its off-balance-sheet credit exposures and guarantees. “Nominal” in this context is a fair-value assessment, not a claim that default is impossible or that the notional value of cleared contracts is negligible. The safeguards are designed precisely because extreme losses can occur.[1][3]

CME’s public safeguards page sets out the waterfall. Resources of the defaulting clearing member are used first. CME then contributes designated corporate capital—$100 million for the base futures-and-options service and $150 million for interest-rate swaps—before mutualised guaranty-fund resources and assessment powers are used. The September 30 package listed a $7.556 billion base guaranty-fund requirement and $2.650 billion for IRS, alongside far larger initial-margin totals.[2][3]

The last caution is essential. The safeguards page’s $347.8 billion of combined initial margin exceeds the $155.2 billion consolidated collateral asset because the measures do not share one accounting perimeter. Margin can be posted in forms and arrangements that do not all appear in the same balance-sheet line. The figures describe risk resources, not additive piles of CME-owned assets.[1][2]

Liquidity backstops sit beside, not inside, the headline asset total

CME maintains a $7 billion secured revolving credit facility for specified clearing-house liquidity events, including a member failing to discharge an obligation promptly, a custodian default or a payment-system disruption. At September 30, $10.2 billion of guaranty-fund contributions was available to collateralise that facility. The line supplies temporary liquidity against eligible collateral; it is not $7 billion of cash already drawn, and the $10.2 billion is part of clearing resources rather than an additional corporate asset to add to the balance sheet.[1]

This distinction matters during stress. A clearing house can have abundant collateral but still need immediate liquidity in the right currency and account before default resources can be converted or transferred. Conversely, access to a credit facility does not absorb ultimate losses; it bridges timing. Solvency resources, collateral and liquidity facilities solve related but different problems.[1][3]

What the evidence establishes

CME’s filing proves that $155.180 billion of its $192.093 billion asset total was matched performance-bond and guaranty-fund collateral at quarter-end, and that the same amount appeared as a liability. It proves that $139.1 billion was held in the Fed account and that collateral generated large gross interest flows with most interest distributed to clearing firms. It does not prove that the residual $36.913 billion is free cash, that all posted margin appears on balance sheet or that a nominal fair-value guarantee has no stress risk.[1]

The original finding is a balance-sheet denominator correction. CME is a systemically important clearing house, so the $192 billion total is economically real. But four-fifths of it represents a matched, restricted clearing mechanism rather than shareholder capital. Investors, clearing members and policymakers should therefore read the asset line together with its equal liability, the net collateral-interest bridge, the default waterfall and the liquidity backstop. Without those four pieces, gross size says almost nothing about the resources CME can deploy for its own account.[1][2][3]

Report an error or submit an update